Tuberculosis Trial, Recruiting NCT07086820 Sponsor: Pontificia Universidad Catolica de Chile Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT07086820
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You live in the same household as someone who has recently been diagnosed with a confirmed case of tuberculosis (TB) in their lungs
  • You are between 5 and 17 years old (at least 5, but not yet 18)

Who may not be able to join:

  • You show signs of having active TB yourself, based on a physical check-up or imaging (such as a chest X-ray)
  • You are currently pregnant or breastfeeding
  • You have a weakened immune system (for example, due to a medical condition or medication that affects your body's ability to fight infection)
  • You have a known allergy or medical reason why you cannot take the medications isoniazid or rifapentine
  • You have a long-term liver condition or a problem with alcohol use
  • You have previously been treated for either active TB or a latent (inactive/sleeping) TB infection
  • You have previously had a tuberculin skin test (a common test used to check for TB exposure)
  • The person in your household who has TB has a type that is known or suspected to be resistant to standard TB drugs
  • The person in your household who has TB has been living away from home for more than four weeks
  • You have already received more than 15 daily doses of TB medication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +56 955043508

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pontificia Universidad Catolica de Chile
Registry
ClinicalTrials.gov
Start date
27 October 2025
Est. completion
1 May 2028

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Incidence of new tuberculosis infections (all IGRA conversions) from enrollment until the end of follow-up in both study arms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov